These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10342641)

  • 1. What's new in HIV.
    Morris-Jones S; Nelson MR
    J Infect; 1999 Mar; 38(2):i-ii. PubMed ID: 10342641
    [No Abstract]   [Full Text] [Related]  

  • 2. The daunting challenge of keeping HIV suppressed.
    Cohen J
    Science; 1997 Jul; 277(5322):32-3. PubMed ID: 9229768
    [No Abstract]   [Full Text] [Related]  

  • 3. Higher antiviral activity of antiretroviral regimens including protease inhibitors.
    de Mendoza C; Soriano V; Rodríguez-Rosado R; González-Lahoz J
    AIDS; 1999 May; 13(8):998-9. PubMed ID: 10371186
    [No Abstract]   [Full Text] [Related]  

  • 4. Salvage therapy for patients failing their current antiretroviral regimen.
    Albrecht MA
    AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220
    [No Abstract]   [Full Text] [Related]  

  • 5. [New trends in HIV].
    Volkert R
    Dtsch Med Wochenschr; 1998 Sep; 123(38):A7. PubMed ID: 9787287
    [No Abstract]   [Full Text] [Related]  

  • 6. [HIV viral dynamic after antiretroviral treatment initiation: is a rapid decay a good pronostic?].
    Delaugerre C
    Pathol Biol (Paris); 2010 Dec; 58(6):403-5. PubMed ID: 19481371
    [No Abstract]   [Full Text] [Related]  

  • 7. [Human immunodeficiency virus and antiretroviral therapy resistance].
    Quirós E; Torti C; Carosi G
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):234-7. PubMed ID: 10974768
    [No Abstract]   [Full Text] [Related]  

  • 8. Update of the drug resistance mutations in HIV-1: 2004.
    Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD
    Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709
    [No Abstract]   [Full Text] [Related]  

  • 9. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
    Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
    J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
    [No Abstract]   [Full Text] [Related]  

  • 10. The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS).
    De Clercq E
    Adv Pharmacol; 2013; 67():317-58. PubMed ID: 23886005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting HIV: antiretroviral therapy and development of drug resistance.
    Menéndez-Arias L
    Trends Pharmacol Sci; 2002 Aug; 23(8):381-8. PubMed ID: 12377580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral treatment of HIV infection.
    Thomas MG; Ellis-Pegler RB
    N Z Med J; 1998 Sep; 111(1074):353-4. PubMed ID: 11039818
    [No Abstract]   [Full Text] [Related]  

  • 13. [The 39th ICAAC (San Francisco) and the 7th European Conference on Clinical Aspects and Treatment of HIV-infection (Lisbon). HIV infection: antiretroviral agents in the development and trial stage].
    Duval X
    Presse Med; 2000 Feb; 29(5):253-6. PubMed ID: 10701407
    [No Abstract]   [Full Text] [Related]  

  • 14. Developing long-term treatment strategies.
    PI Perspect; 1996 Sep; (No 19):11-4. PubMed ID: 11363897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-HIV drugs].
    Raffi F
    Rev Prat; 1999 Oct; 49(16):1763-71. PubMed ID: 10578607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.
    Gallego O; Ruiz L; Vallejo A; Ferrer E; Rubio A; Clotet B; Leal M; Soriano V;
    AIDS; 2001 Sep; 15(14):1894-6. PubMed ID: 11579258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy: where are we?
    Hammer SM; Yeni P
    AIDS; 1998; 12 Suppl A():S181-8. PubMed ID: 9633001
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiretroviral update: recent advances expand options for patients with HIV.
    Santhanam H; Goins M
    Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
    [No Abstract]   [Full Text] [Related]  

  • 19. ICAAC eyes PIs, NNRTIs, and STIs.
    Mascolini M
    IAPAC Mon; 2000 Dec; 6(12):362-75. PubMed ID: 11299547
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?
    Uy J; Brooks JT; Baker R; Hoffman M; Moorman A; Novak R;
    Antivir Ther; 2007; 12(6):957-62. PubMed ID: 17926650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.